Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-16
DOI: 10.2147/dddt.s598274 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Veerendra Kumar Panuganti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Affairs, Shilpa Medicare Limited, Hyderabad, Telangana, 500076, India. Hauptthemen laut MEDLINE: Serum Albumin, Serum Albumin, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Affairs, Shilpa Medicare Limited, Hyderabad, Telangana, 500076, India.
- Medical Affairs Department, Shilpa Medicare Limited, Hyderabad, Telangana, 500076, India.
- Shilpa Biologicals Private Limited, Dharwad, Karnataka, 580011, India.
- Bioanalytical Laboratory, Shilpa Medicare Ltd, Hyderabad, Telangana, 500076, India.
ORCID-Profile: Javeed Mohammad
Zitieren
APA
Panuganti, V. K., Dundigalla, M. R., Grandhi, V. R., Khambhampaty, S., Madala, P. K., Mohammad, J., Shaik, A., Shaik, M. B., Kssvv, S., & Sangeetham, S. K. (2026). Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s598274
Vancouver
Panuganti VK, Dundigalla MR, Grandhi VR, Khambhampaty S, Madala PK, Mohammad J, et al. Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s598274
BibTeX
@article{Panuganti2026,
author = {Panuganti, Veerendra Kumar and Dundigalla, Mamatha Reddy and Grandhi, Venkata Ramalingayya and Khambhampaty, Sridevi and Madala, Pavan Kumar and Mohammad, Javeed and Shaik, Althaf and Shaik, Mahaboob Basha and Kssvv, Sanyasirao and Sangeetham, Sai Kumar},
title = {Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--16},
doi = {10.2147/dddt.s598274}
}
EUVIMED